An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

Two factors contribute to Burkitt lymphoma (BL) pathogenesis, a chromosomal translocation leading to c-myc oncogene deregulation and infection with Epstein-Barr virus (EBV). Although the virus has B cell growth-transforming ability, this may not relate to its role in BL since many of the transformin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gemma L Kelly, Heather M Long, Julianna Stylianou, Wendy A Thomas, Alison Leese, Andrew I Bell, Georg W Bornkamm, Josef Mautner, Alan B Rickinson, Martin Rowe
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
Acceso en línea:https://doaj.org/article/cba3c46e566143f5bbe3462e7f791529
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cba3c46e566143f5bbe3462e7f791529
record_format dspace
spelling oai:doaj.org-article:cba3c46e566143f5bbe3462e7f7915292021-11-25T05:47:12ZAn Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.1553-73661553-737410.1371/journal.ppat.1000341https://doaj.org/article/cba3c46e566143f5bbe3462e7f7915292009-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19283066/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Two factors contribute to Burkitt lymphoma (BL) pathogenesis, a chromosomal translocation leading to c-myc oncogene deregulation and infection with Epstein-Barr virus (EBV). Although the virus has B cell growth-transforming ability, this may not relate to its role in BL since many of the transforming proteins are not expressed in the tumor. Mounting evidence supports an alternative role, whereby EBV counteracts the high apoptotic sensitivity inherent to the c-myc-driven growth program. In that regard, a subset of BLs carry virus mutants in a novel form of latent infection that provides unusually strong resistance to apoptosis. Uniquely, these virus mutants use Wp (a viral promoter normally activated early in B cell transformation) and express a broader-than-usual range of latent antigens. Here, using an inducible system to express the candidate antigens, we show that this marked apoptosis resistance is mediated not by one of the extended range of EBNAs seen in Wp-restricted latency but by Wp-driven expression of the viral bcl2 homologue, BHRF1, a protein usually associated with the virus lytic cycle. Interestingly, this Wp/BHRF1 connection is not confined to Wp-restricted BLs but appears integral to normal B cell transformation by EBV. We find that the BHRF1 gene expression recently reported in newly infected B cells is temporally linked to Wp activation and the presence of W/BHRF1-spliced transcripts. Furthermore, just as Wp activity is never completely eclipsed in in vitro-transformed lines, low-level BHRF1 transcripts remain detectable in these cells long-term. Most importantly, recognition by BHRF1-specific T cells confirms that such lines continue to express the protein independently of any lytic cycle entry. This work therefore provides the first evidence that BHRF1, the EBV bcl2 homologue, is constitutively expressed as a latent protein in growth-transformed cells in vitro and, in the context of Wp-restricted BL, may contribute to virus-associated lymphomagenesis in vivo.Gemma L KellyHeather M LongJulianna StylianouWendy A ThomasAlison LeeseAndrew I BellGeorg W BornkammJosef MautnerAlan B RickinsonMartin RowePublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 5, Iss 3, p e1000341 (2009)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Gemma L Kelly
Heather M Long
Julianna Stylianou
Wendy A Thomas
Alison Leese
Andrew I Bell
Georg W Bornkamm
Josef Mautner
Alan B Rickinson
Martin Rowe
An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
description Two factors contribute to Burkitt lymphoma (BL) pathogenesis, a chromosomal translocation leading to c-myc oncogene deregulation and infection with Epstein-Barr virus (EBV). Although the virus has B cell growth-transforming ability, this may not relate to its role in BL since many of the transforming proteins are not expressed in the tumor. Mounting evidence supports an alternative role, whereby EBV counteracts the high apoptotic sensitivity inherent to the c-myc-driven growth program. In that regard, a subset of BLs carry virus mutants in a novel form of latent infection that provides unusually strong resistance to apoptosis. Uniquely, these virus mutants use Wp (a viral promoter normally activated early in B cell transformation) and express a broader-than-usual range of latent antigens. Here, using an inducible system to express the candidate antigens, we show that this marked apoptosis resistance is mediated not by one of the extended range of EBNAs seen in Wp-restricted latency but by Wp-driven expression of the viral bcl2 homologue, BHRF1, a protein usually associated with the virus lytic cycle. Interestingly, this Wp/BHRF1 connection is not confined to Wp-restricted BLs but appears integral to normal B cell transformation by EBV. We find that the BHRF1 gene expression recently reported in newly infected B cells is temporally linked to Wp activation and the presence of W/BHRF1-spliced transcripts. Furthermore, just as Wp activity is never completely eclipsed in in vitro-transformed lines, low-level BHRF1 transcripts remain detectable in these cells long-term. Most importantly, recognition by BHRF1-specific T cells confirms that such lines continue to express the protein independently of any lytic cycle entry. This work therefore provides the first evidence that BHRF1, the EBV bcl2 homologue, is constitutively expressed as a latent protein in growth-transformed cells in vitro and, in the context of Wp-restricted BL, may contribute to virus-associated lymphomagenesis in vivo.
format article
author Gemma L Kelly
Heather M Long
Julianna Stylianou
Wendy A Thomas
Alison Leese
Andrew I Bell
Georg W Bornkamm
Josef Mautner
Alan B Rickinson
Martin Rowe
author_facet Gemma L Kelly
Heather M Long
Julianna Stylianou
Wendy A Thomas
Alison Leese
Andrew I Bell
Georg W Bornkamm
Josef Mautner
Alan B Rickinson
Martin Rowe
author_sort Gemma L Kelly
title An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
title_short An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
title_full An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
title_fullStr An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
title_full_unstemmed An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
title_sort epstein-barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the wp/bhrf1 link.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/cba3c46e566143f5bbe3462e7f791529
work_keys_str_mv AT gemmalkelly anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT heathermlong anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT juliannastylianou anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT wendyathomas anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT alisonleese anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT andrewibell anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT georgwbornkamm anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT josefmautner anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT alanbrickinson anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT martinrowe anepsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT gemmalkelly epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT heathermlong epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT juliannastylianou epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT wendyathomas epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT alisonleese epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT andrewibell epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT georgwbornkamm epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT josefmautner epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT alanbrickinson epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
AT martinrowe epsteinbarrvirusantiapoptoticproteinconstitutivelyexpressedintransformedcellsandimplicatedinburkittlymphomagenesisthewpbhrf1link
_version_ 1718414485547384832